SEC Form 4 · accession 0000899243-18-007081
Corvus Pharmaceuticals, Inc. · CRVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Miller M.D.
Officer — President and CEO · Director
Period of report
Mar 12, 2018
Accepted (ET)
Mar 12, 2018 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par valueF2,F3 | Mar 12, 2018 | P | 100,000 | $8.50 | A | 1,112,293 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting Person purchased 100,000 shares of Issuer's common stock in connection with a public offering at the offering price of $8.50 per share.
- F2A portion of these shares is subject to a right of repurchase held by the Issuer.
- F3These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.